Antimicrobial resistance is an urgent threat to public health and global development; in this
scenario, the SARS-CoV2 pandemic has caused a major disruption of healthcare systems …

Invasive fungal infections (IFIs) can complicate the clinical course of COVID-19 and are
associated with a significant increase in mortality, especially in critically ill patients admitted …

Background Increased hospitalisation rates in the Coronavirus disease 19 (COVID‐19) era
lead to a new wave of hospital‐acquired infections such as emerging multidrug‐resistant …

Abstract The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is threatening public health. A large number of …

Atypical Candida spp. infections are rising, mostly due to the increasing numbers of
immunocompromised patients. The most common Candida spp. is still Candida albicans; …

Patients with severe COVID-19, such as individuals in intensive care units (ICU), are
exceptionally susceptible to bacterial and fungal infections. The most prevalent fungal …

Severe cases of coronavirus disease 2019 (COVID-19) managed in the intensive care unit
are prone to complications, including secondary infections with opportunistic fungal …

Candida auris is a major emerging human fungal pathogen that was first reported in 2009 as
an isolate from the ear canal of a patient in Japan [1]. Since this initial report, C. auris has …

The incidence of COVID-19-associated candidiasis (CAC) is increasing, resulting in a grave
outcome among hospitalized patients with COVID-19. The most alarming condition is the …

There is scarce information on the actual incidence of candidemia in COVID-19 patients. In
addition, comparative studies of candidemia episodes in COVID-19 and non-COVID-19 …